Literature DB >> 2243092

Structural and functional analysis of the human thymidylate synthase gene.

S Kaneda1, J Nalbantoglu, K Takeishi, K Shimizu, O Gotoh, T Seno, D Ayusawa.   

Abstract

The complete nucleotide sequence of the human thymidylate synthase (TS) gene was determined. The biologically active unit spans about 16 kilobase pairs (kbp) and is composed of seven exons and six introns. The promoter region and the major transcriptional start sites were located within about 400 base pairs (bp) and 160-180 bp, respectively, upstream from the ATG initiation codon. A minigene consisting of a 5'-flanking sequence of about 4 kbp, a coding sequence of about 1.7 kpb was sufficient for cell cycle-dependent expression of TS when introduced into a TS-deficient mutant of rodent cells. The 5'-flanking region does not contain a "TATA," "CAAT," or the consensus sequence for Sp1 binding (GC box), whereas intron 1 contains three GC boxes. The gene is G + C-rich and the CpG-rich region extends from 5'-flanking region to intron 1. These sequence characteristics were compared with those of the mouse TS gene and other cell cycle-regulated genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2243092

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents.

Authors:  Norman H Lee
Journal:  Anticancer Agents Med Chem       Date:  2010-10-01       Impact factor: 2.505

Review 2.  The role of pharmacogenetics in cancer therapeutics.

Authors:  Wei Peng Yong; Federico Innocenti; Mark J Ratain
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

3.  Genetic variants in the enhancer region of the thymidylate synthase gene in the Chilean population.

Authors:  M Acuña; L Eaton; L Cifuentes; D Massardo
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

4.  Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis.

Authors:  Niveditha Muralidharan; Durga P Misra; Vikramraj K Jain; Vir Singh Negi
Journal:  Clin Rheumatol       Date:  2017-03-27       Impact factor: 2.980

5.  Identification of an RNA binding site for human thymidylate synthase.

Authors:  E Chu; D Voeller; D M Koeller; J C Drake; C H Takimoto; G F Maley; F Maley; C J Allegra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

6.  Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA.

Authors:  B J Dolnick
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

7.  Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Authors:  Aurea Lima; Vítor Seabra; Sandra Martins; Ana Coelho; António Araújo; Rui Medeiros
Journal:  Mol Biol Rep       Date:  2014-02-20       Impact factor: 2.316

8.  Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer.

Authors:  Kai-Huan Yu; Wei-Xing Wang; You-Ming Ding; Hui Li; Ze-Sheng Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

9.  Characterization of the transcriptional regulatory region of the human dihydrolipoamide dehydrogenase gene.

Authors:  G L Johanning; J I Morris; K T Madhusudhan; D Samols; M S Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 10.  MCB elements and the regulation of DNA replication genes in yeast.

Authors:  E M McIntosh
Journal:  Curr Genet       Date:  1993-09       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.